Close Menu

NEW YORK – Quanterix provided on Wednesday a financial update projecting Q4 2020 revenues of between $24 and $26 million, which would represent between a 51 percent and 63 percent increase over the $15.9 million in revenues the company reported in Q4 2019.

On a non-GAAP basis, revenues for the recently completed quarter are expected to be between $20 million and $22 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.